4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-26-000034
Chief Executive Officer acquired 232,252 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venker Eric Chief Executive Officer | 2026-04-07 | Grant or award | +232,252 | 251,813 | D | ||
| Derivatives | |||||||
| Venker Eric Chief Executive Officer | 2026-04-07 | Grant or award · Stock Option (right to buy) | +336,043 | 336,043 | D | ||
Loading xslF345X06/wk-form4_1775765620.xml…